Rhodiola Rosea vs Selank
Two anxiety/stress compounds from very different traditions — a synthetic Russian anxiolytic peptide claimed to match benzodiazepines, against an adaptogenic root with a genuine, if modest, placebo-controlled trial record.
Rhodiola Rosea
Several placebo-controlled RCTs show a short-term benefit for stress-related fatigue and mental performance — but trials are small/lower-quality and systematic reviews call it promising, not proven.
Full Rhodiola Rosea evidence reviewSelank
A GABA-modulating anxiolytic that matched benzodiazepines in small Russian trials; the mechanism is credible but the evidence base is thin and single-country.
Full Selank evidence reviewSide by side
| Rhodiola Rosea | Selank | |
|---|---|---|
| Marketed for | Stress, fatigue, focus | Anxiety, focus |
| Evidence grade | Clinical data | Clinical data |
| Family | mTOR & other | Nootropic / cognitive |
| Key human source | Olsson RCT, Planta Med 2009 | Medvedev, Korsakov J 2015 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
Selank's evidence is a GABA-modulating mechanism that matched benzodiazepines in small Russian trials — credible mechanism, but the evidence base is thin and effectively single-country. Rhodiola has a broader, if lower-quality, body of placebo-controlled trials specifically for stress-related fatigue and mental performance, with systematic reviews calling it promising rather than proven.
Rhodiola Rosea fits if
You want the more accessible, more internationally studied option for everyday stress and fatigue.
Selank fits if
You're specifically interested in the peptide/nasal-spray route and the GABA-modulation mechanism, accepting the evidence is single-country.
Where to get it
Where to get peptide therapy
Clinician-led telehealth services that prescribe compounded peptides. The specific peptides offered vary by provider — confirm Selank availability before ordering.
